4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Oramed Pharmaceuticals Inc. (ORMP) operates in the Biotechnology industry and is headquartered in New York, United States. Its market capitalization is roughly $168 million. In the fiscal year ended 2025-12-31, ORMP reported $2M in revenue and $64M in net income.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $2M | $0M | $1M | $3M |
| Gross Profit | $0M | $0M | — | — |
| Operating Income (EBIT) | ($15M) | ($13M) | ($16M) | ($41M) |
| Net Income | $64M | ($19M) | $6M | ($37M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $2M | — |
| Gross Profit | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($4M) | ($6M) | ($2M) | ($2M) | ($4M) | — |
| Net Income | $38M | $10M | $48M | $13M | ($8M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | ($10M) | — | — | — | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-08-31 |
|---|---|---|---|---|---|
| Total Assets | $231M | $155M | $221M | $162M | — |
| Total Liabilities | $31M | $10M | $58M | $10M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ORMP viewer.
About TickerBase · Data methodology & sources